Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas.

Autor: Sánchez-Castillo A; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Savelkouls KG; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Baldini A; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Hounjet J; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Sonveaux P; Pole of Pharmacology, Institut de Recherche Experimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.; WEL Research Institute, WELBIO Department, Wavre, Belgium., Verstraete P; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., De Keersmaecker K; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Dewaele B; Center for Human Genetics, Laboratory for Genetics of Malignant Disorders, University Hospitals Leuven and KU Leuven, Leuven, Belgium., Björkblom B; Department of Chemistry, Umeå University, Umeå, Sweden., Melin B; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Wu WY; Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden., Sjöberg RL; Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden., Rouschop KMA; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Broen MPG; Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Vooijs M; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands., Kampen KR; Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center, GROW School for Oncology and Reproduction, Maastricht, The Netherlands. k.kampen@maastrichtuniversity.nl.; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. k.kampen@maastrichtuniversity.nl.

Publikováno v: Oncogenesis [Oncogenesis] 2024 Nov 13; Vol. 13 (1), pp. 39. Date of Electronic Publication: 2024 Nov 13.

Use of the experience sampling method in adolescents with Duchenne muscular dystrophy: a feasibility study.

Autor: Lionarons JM; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.lionarons@outlook.com.; Center for Neurological Learning Disabilities, Kempenhaeghe, Heeze, The Netherlands. j.lionarons@outlook.com.; Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands. j.lionarons@outlook.com., Delespaul PAEG; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.; Department of Adult Psychiatry, Mondriaan Mental Health Trust, Heerlen, The Netherlands., Hellebrekers DMJ; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.; Center for Neurological Learning Disabilities, Kempenhaeghe, Heeze, The Netherlands.; Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands., Broen MPG; Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands., Klinkenberg S; Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands., Faber CG; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.; Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands., Hendriksen JGM; Center for Neurological Learning Disabilities, Kempenhaeghe, Heeze, The Netherlands.; Duchenne Centre Netherlands, Leiden, The Netherlands., Vles JSH; School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Publikováno v: European child & adolescent psychiatry [Eur Child Adolesc Psychiatry] 2024 Jul; Vol. 33 (7), pp. 2281-2290. Date of Electronic Publication: 2023 Nov 01.

Survival after resection of malignant peripheral nerve sheath tumors: Introducing and validating a novel type-specific prognostic model.

Autor: Acem I; Department of Surgical Oncology and Gastrointestinal Surgery,Erasmus MC Cancer Institute, >Rotterdam, The Netherlands.; Department of Orthopedic Oncology, Leiden University Medical Centre, >Leiden, The Netherlands., Steyerberg EW; Department of Biomedical Data Sciences, Leiden University Medical Centre, >Leiden, The Netherlands., Spreafico M; Department of Medical Statistics, Mathematical Institute, Leiden University, >Leiden, The Netherlands., Grünhagen DJ; Department of Surgical Oncology and Gastrointestinal Surgery,Erasmus MC Cancer Institute, >Rotterdam, The Netherlands., Callegaro D; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, >Milan, Italy., Spinner RJ; Department of Neurosurgery, Mayo Clinic, >Rochester, Minnesota, USA., Pendleton C; Department of Neurosurgery, Stony Brook University School of Medicine, Stony Brook, New York, USA., Coert JH; Department of Reconstructive Surgery, University Medical Centre Utrecht, >Utrecht, The Netherlands., Miceli R; Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, >Milan, Italy., Abruzzese G; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, >Milan, Italy., Flucke UE; Department of Pathology, Radboud University Medical Centre, >Nijmegen, The Netherlands., Slooff WM; Department of Neurosurgery, University Medical Centre Utrecht, >Utrecht, The Netherlands., van Dalen T; Department of Surgical Oncology and Gastrointestinal Surgery,Erasmus MC Cancer Institute, >Rotterdam, The Netherlands., Been LB; Department of Surgical Oncology, University Medical Centre Groningen, Groningen, The Netherlands., Bonenkamp HJ; Department of Surgical Oncology, Radboud University Medical Centre, >Nijmegen, The Netherlands., Anten MHME; Department of Neurology, Maastricht University Medical Centre, >Maastricht, The Netherlands., Broen MPG; Department of Neurology, Maastricht University Medical Centre, >Maastricht, The Netherlands., Bemelmans MHA; Department of Surgical Oncology, Maastricht University Medical Centre, >Maastricht, The Netherlands., Bramer JAM; Department of Orthopedic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Schaap GR; Department of Orthopedic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Kievit AJ; Department of Orthopedic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., van der Hage J; Department of Surgical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van de Sande MAJ; Department of Orthopedic Oncology, Leiden University Medical Centre, >Leiden, The Netherlands., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, >Milan, Italy., Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery,Erasmus MC Cancer Institute, >Rotterdam, The Netherlands., Martin E; Department of Reconstructive Surgery, University Medical Centre Utrecht, >Utrecht, The Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2024 Jun 05; Vol. 6 (1), pp. vdae083. Date of Electronic Publication: 2024 Jun 05 (Print Publication: 2024).

Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.

Autor: Verduin M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Hoosemans L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Vanmechelen M; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; LISCO-KU Leuven Institute for Single Cell Omics, KU Leuven, Leuven, Belgium., van Heumen M; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Piepers JAF; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Astuti G; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Ackermans L; Department of Neurosurgery, School for Mental Health and Neuroscience (MHeNS), Maastricht University Medical Center, Maastricht, The Netherlands., Schijns OEMG; Department of Neurosurgery, School for Mental Health and Neuroscience (MHeNS), Maastricht University Medical Center, Maastricht, The Netherlands.; Academic Center for Epileptology, Maastricht University Medical Center and Kempenhaeghe, Maastricht-Heeze, The Netherlands., Kampen KR; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.; Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Leuven, Belgium., Tjan-Heijnen VCG; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., de Barbanson BA; Barbanson Biotech., Postma AA; Department of Radiology and Nuclear Medicine, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands., Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Broen MPG; Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands., Beckervordersandforth J; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Staňková K; Institute for Health Systems Science, Delft University of Technology, Delft, The Netherlands., de Smet F; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.; LISCO-KU Leuven Institute for Single Cell Omics, KU Leuven, Leuven, Belgium., Rich J; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hubert CG; Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Gimenez G; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Chatterjee A; Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Hoeben A; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands., Vooijs MA; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2023 Nov 25; Vol. 5 (1), pp. vdad152. Date of Electronic Publication: 2023 Nov 25 (Print Publication: 2023).

Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain.

Autor: Zegers CML; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., Offermann C; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., Dijkstra J; Department of Medical Psychology Maastricht University Medical Center+, MHeNs School for Mental Health and Neuroscience, Maastricht, the Netherlands., Compter I; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., Hoebers FJP; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., de Ruysscher D; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., Anten MM; Department of Neurology, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Broen MPG; Department of Neurology, GROW - School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Postma AA; Department of Radiology & Nuclear Medicine, Maastricht University Medical Center+, MHeNs School for Mental Health and Neuroscience, Maastricht, the Netherlands., Hoeben A; Dept of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., Hovinga KE; Department of Neurosurgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands., Van Elmpt W; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands., Eekers DBP; Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW-School for Oncology and Reproduction, Maastricht, the Netherlands.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2023 Jul 22; Vol. 42, pp. 100664. Date of Electronic Publication: 2023 Jul 22 (Print Publication: 2023).